TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Zhaoke Ophthalmology Ltd. ( (HK:6622) ) is now available.
Zhaoke Ophthalmology Ltd. announced the grant of 8,000,000 share options to 97 grantees, including employees and directors, under its Post-IPO Share Option Scheme. This move, effective from September 5, 2025, aims to enhance the company’s competitive remuneration package, attract and retain talent, and ensure the independence and impartiality of its independent non-executive directors.
The most recent analyst rating on (HK:6622) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on Zhaoke Ophthalmology Ltd. stock, see the HK:6622 Stock Forecast page.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Ltd. is a company incorporated in the British Virgin Islands and continued in the Cayman Islands, focusing on the ophthalmology industry. The company is listed on the Hong Kong Stock Exchange and is involved in developing and providing eye care solutions.
Average Trading Volume: 3,179,397
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
See more data about 6622 stock on TipRanks’ Stock Analysis page.